India, July 27 -- Shares of Forte Biosciences, Inc. (FBRX) jumped 40% on Monday morning after argenx (ARGX) agreed to acquire the clinical-stage biotechnology company in an all-cash deal valued at approximately $2.2 billion.
The stock is currently trading at $76.45, up $21.67 or 39.56%, on the Nasdaq. It opened at $76.42 after closing the previous session at $54.78. The stock has traded between $9.10 and $76.48 over the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....